Immune Disorders Drugs Market Research Reports

Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 - Growth Driven by Rising Awareness and Expected Launch of Novel Therapies - Product Thumbnail Image

Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 - Growth Driven by Rising Awareness and Expected Launch of Novel Therapies

  • Report
  • 113 Pages
From
Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry - Product Thumbnail Image

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry

  • Report
  • 180 Pages
From
Biological Autoimmune Therapeutics - Product Thumbnail Image

Biological Autoimmune Therapeutics

  • Report
From
Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018

  • Report
  • 98 Pages
From
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies - Product Thumbnail Image

HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies

  • Report
  • 92 Pages
From
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs - Product Thumbnail Image

Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

  • Report
  • 181 Pages
From
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market - Product Thumbnail Image

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • Report
  • 125 Pages
From
Immunotherapeutic Drugs, Devices & Patient Enablement - Product Thumbnail Image

Immunotherapeutic Drugs, Devices & Patient Enablement

  • Report
From
Global Cancer Monoclonal Antibodies Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Monoclonal Antibodies Market & Clinical Trial Insight 2024

  • Clinical Trials
  • 1100 Pages
From
Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), Application (Lung, Breast, Multiple Myeloma, Colorectal, Melanoma, Prostate), And End User– Global Forecast To 2024 - Product Thumbnail Image

Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), Application (Lung, Breast, Multiple Myeloma, Colorectal, Melanoma, Prostate), And End User– Global Forecast To 2024

  • Report
  • 173 Pages
From
Epiomic Epidemiology Series: Primary Immunodeficiency Diseases Forecast In 23 Major Markets 2018-2028 - Product Thumbnail Image

Epiomic Epidemiology Series: Primary Immunodeficiency Diseases Forecast In 23 Major Markets 2018-2028

  • Report
  • 66 Pages
From
Research Antibodies and Reagents Market - Global Opportunity Analysis and Industry Forecast (2018-2023) - Product Thumbnail Image

Research Antibodies and Reagents Market - Global Opportunity Analysis and Industry Forecast (2018-2023)

  • Report
  • 321 Pages
From
Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market - Product Thumbnail Image

Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market

  • Report
  • 91 Pages
From
Epiomic Epidemiology Series: Mucopolysaccharidosis Type I Forecast In 27 Major Markets 2018–2028 - Product Thumbnail Image

Epiomic Epidemiology Series: Mucopolysaccharidosis Type I Forecast In 27 Major Markets 2018–2028

  • Report
  • 74 Pages
From
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay, Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023 - Product Thumbnail Image

Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay, Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023

  • Report
  • 158 Pages
From
Immunochemicals - Global Strategic Business Report - Product Thumbnail Image

Immunochemicals - Global Strategic Business Report

  • Report
  • 281 Pages
From
Frontier Pharma: Women's Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline - Product Thumbnail Image

Frontier Pharma: Women's Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline

  • Report
  • 86 Pages
From
Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report - Product Thumbnail Image

Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report

  • Report
  • 187 Pages
From
Fibromyalgia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Therapeutics - Global Strategic Business Report

  • Report
  • 78 Pages
From
Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application, By End Use, By Region, And Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application, By End Use, By Region, And Segment Forecasts, 2018 - 2025

  • Report
  • 109 Pages
From
Loading Indicator
adroll